J. Taubert serves as the Executive Vice President (EVP) of WWC Innovative Medicine at Johnson & Johnson, a position where he plays a pivotal role in steering the company's efforts in developing and delivering innovative healthcare solutions globally. With a robust career spanning several decades in the pharmaceutical industry, Taubert has been instrumental in driving Johnson & Johnson's strategic initiatives, particularly in the areas of research, development, and commercialization of new medicines. His leadership has been crucial in advancing the company's mission to improve patient outcomes and address unmet medical needs worldwide. Before joining Johnson & Johnson, Taubert held various high-level positions in the healthcare sector, where he honed his skills in strategic planning and operational management. His career is marked by significant achievements, including leading successful product launches and fostering collaborations that have resulted in groundbreaking medical advancements. At Johnson & Johnson, Taubert's role involves overseeing a diverse portfolio of innovative medicines, ensuring that the company remains at the forefront of medical innovation. His strategic vision and commitment to excellence have made him a respected leader within the organization and the broader industry.